Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 621

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases

Open access
Jager, Kitty J, Kovesdy, Csaba, Langham, Robyn, Rosenberg, Mark, Jha, Vivekanand, Zoccali, Carmine · 2019 · Nephrology Dialysis Transplantation

Abstract

On a world scale the total number of individuals with chronic kidney disease (CKD), acute kidney injury (AKI) and those on renal replacement therapy (RRT) exceeds 850 million, a truly concerning figure that is twice the estimated number of people with diabetes worldwide and >20 times higher than the number of individuals affected by acquired immune deficiency syndrome (AIDS)/human immunodeficiency virus (HIV) worldwide. Thus kidney diseases are one of the most common diseases worldwide. CKD is now an unquestionable global public priority [1, 2]. Even though the prevalence of CKD and its impact on health has been mainly studied in economically developed countries, the burden of this disease is even greater in developing countries [3, 4]. In 2016, this disease was 13th on the list of causes of death on a world scale [5] and in 2040 it is expected to be the 5th leading cause of years of life lost [6]. In 2010, 2.6 million individuals were receiving some form of kidney replacement therapy worldwide, but an almost equal number might have died during the same year because of a lack of access to dialysis and transplantation [7]. This scenario contrasts with that of other major chronic diseases, such as cardiovascular diseases and respiratory diseases, whose effects on mortality are declining [8]. In spite of this recent recognition of the adverse impact of CKD on health outcomes, awareness of the magnitude and the risks of this condition remain low at the population level. As a result, kidney disease has been largely overlooked by health authorities and governments in most countries [9]. Even in the USA, a 2016 survey [10] showed that CKD awareness in the community is substantially lower as compared with that of other chronic diseases such as hypertension and diabetes [11]. Kidney diseases cover a wide spectrum of diseases with diverse aetiologies, clinical courses and functional severity, from AKI to the various CKD stages from Stage 1 to Stage 5 and include end-stage kidney disease, which demands chronic dialysis and renal transplantation. Several countries have now produced rich, articulated and very detailed CKD statistics. However, the degree of complexity of these statistics is such that they are not easily used for communication with the public and with decision makers. The differentiation of CKD into stages and the separate consideration of the epidemiology of patients on RRTs (dialysis and transplantation) are fundamental in professional and scientific terms but are too complex to serve as a basis for broad-based communication. AKI, related to basic public health challenges, continues to be an important cause of entirely preventable deaths throughout the developing world. Survivors are at increased risk of developing CKD. Fragmentation of discussion by framing these conditions separately leads to the removal of focus from the importance of the health burden imposed on the society by disruption of normal kidney function. A simplification effort is needed if we are to increase awareness of the extent of the magnitude of kidney diseases on a global scale. Producing a single, absolute number of individuals affected by kidney diseases will effectively convey to the interested parties the large and growing relevance of the problem. Producing simple, immediately understandable statistical figures is fundamental for helping to draw attention to unaddressed public health issues by governments and health authorities and to increase awareness at the community level [12]. The international diabetes community has had significant success in leveraging increased awareness and support by identifying and utilizing a single figure that conveys the global burden of diabetes, a figure that is independent of the type and severity of diabetes [13]. Other examples include depression [14, 15], Alzheimer’s [16] and breast cancer [17]. Thus it is of great importance to have a similar metric to express the burden of kidney diseases across the globe. With this background in mind, the ASN, ERA-EDTA, and ISN in 2017 convened a group charged with producing a simple global estimate of the number of individuals affected by kidney disease, irrespective of aetiology, chronicity, severity or treatment modality. A group of experts representing these societies met twice in face-to-face meetings and held three teleconferences to discuss a pragmatic approach to determining this single number to truly convey the essence of the epidemic facing the global community. The setting date for calculation was the year 2017. In this year, the world population (rounded off to the first decimal) was 7.6 billion [18]. We assumed an equal distribution of the world population between males and females and a homogeneous and stable prevalence of CKD among different parts of the world. The estimate was based on figures reported in the systematic review by Mills et al. [19]. This review collated 33 studies published between 2006 and 2013 reporting gender- and age-

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfz174

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 621

Metadata

Authors
Jager, K. J., Kovesdy, C., Langham, R., Rosenberg, M., Jha, V., & Zoccali, C.
Venue
Nephrology Dialysis Transplantation
Published
2019-09-30
Volume
34
Issue
11
Pages
1803-1805
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2977757007
Cited by
621
References
16
FWCI
23.55
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. https://app.cochat.ai/papers/10.1093/ndt/gfz174
The paper
Jager, K. J., Kovesdy, C., Langham, R., Rosenberg, M., Jha, V., & Zoccali, C. (2019). A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfz174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.